Company profile: Synthesis Med Chem
1.1 - Company Overview
Company description
- Provider of small molecule drug discovery services, offering integrated drug discovery from hit identification to preclinical candidate nomination; medicinal and synthetic chemistry; custom synthesis; targeted protein degradation (PROTACs & molecular glues); antibody-drug conjugate development; and hit discovery supported by protein production and structural biology services from Viva Biotech.
Products and services
- Integrated Drug Discovery: Delivers multi-disciplinary, small-molecule programs by combining medicinal and synthetic chemistry to accelerate hit-to-lead through lead, fitting seamlessly into client teams and advancing hits to preclinical candidate nomination
- Medicinal Chemistry: Architects custom-engineered compound design with project review, SAR analysis, gap finding, new design ideas generation, and patent busting to drive discovery across diverse disease areas
- Synthetic Chemistry & Custom Synthesis: Produces bespoke molecules, from literature compounds to novel targets, with heterocyclic chemistry, natural products, and stable isotope-labeled synthesis capabilities for targeted small-molecule programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synthesis Med Chem
Global Q
HQ: United States
Website
- Description: Provider of cloud-based quality management software and guided compliance with data and complaints management for manufacturers. Solutions include MediGPT for medical device and pharmaceutical firms to improve productivity, cost savings, speed to market and quality; Optiqs360 Digital applying intelligence across operations; IntelliWriter for one-click document automation; and customer success services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Global Q company profile →
Benchling
HQ: United States
Website
- Description: Provider of a cloud-based platform for biology researchers and R&D organizations, including the Benchling R&D Cloud to centralize and standardize scientific data, enable collaboration, and provide insights; Benchling Bioresearch to design and manage experiments, biomolecules, workflows, and results; Benchling Notebook; plus CRISPR guide RNA design and sequence alignment tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Benchling company profile →
DecisionView
HQ: United States
Website
- Description: Provider of web-based software solutions that help life sciences organizations improve clinical trial performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DecisionView company profile →
ChemNavigator
HQ: United States
Website
- Description: Provider of tools and services for scientists to find and procure chemistry for drug discovery, supporting research organizations in the United States and internationally. Offers the ChemNavigator platform to identify and procure chemistry for drug discovery and agrochemical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemNavigator company profile →
Inova
HQ: France
Website
- Description: Provider of digital partnering solutions for the biopharma and life sciences industry, offering Inpart, a platform connecting academic researchers, universities and industry to facilitate collaboration and commercialization; Connect, an algorithm- and machine learning–based matchmaking platform aligning biotech assets with biopharma needs; Deal, a CRM for biopharma partnering; and Event, software for managing in-person or online life science conferences and meetings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inova company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synthesis Med Chem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synthesis Med Chem
2.2 - Growth funds investing in similar companies to Synthesis Med Chem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synthesis Med Chem
4.2 - Public trading comparable groups for Synthesis Med Chem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →